Promotions & Moves

Selexis Makes Scientific and Operational Promotions

Myriam Adam named ops and IP VP; Séverine Fagète named cell line development services VP; and Valérie Le Fourn, research VP

By: Contract Pharma

Contract Pharma Staff

Selexis SA, a JSR Life Sciences Company, has made key promotions across its scientific and operational leadership teams. The following have been promoted: Myriam Adam, Ph.D., to vice president, operations and intellectual property; Séverine Fagète, Ph.D., to vice president, cell line development services; and Valérie Le Fourn, Ph.D., to vice president, research. Myriam joined Selexis in 2012 as project leader, managing and coordinating research, experimental design, process completion, data t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters